These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36877017)

  • 1. Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020).
    Arends SJR; Butler D; Scangarella-Oman N; Castanheira M; Mendes RE
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0152522. PubMed ID: 36877017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S; Weber R; Zbinden R; Ruef C; Hasse B
    Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-Acquired Uropathogenic
    Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
    MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017.
    Critchley IA; Cotroneo N; Pucci MJ; Mendes R
    PLoS One; 2019; 14(12):e0220265. PubMed ID: 31821338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
    Valentine-King M; Zoorob R; Grigoryan L; Trautner B
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management.
    Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Scangarella-Oman NE; Yu K; Ye G; Mitrani-Gold FS
    Clin Infect Dis; 2021 Dec; 73(11):1992-1999. PubMed ID: 34143881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and emerging resistance determinants (blaCTX-M, rmtB, fosA3) in clinical isolates from urinary tract infections in the Bolivian Chaco.
    Bartoloni A; Sennati S; Di Maggio T; Mantella A; Riccobono E; Strohmeyer M; Revollo C; Villagran AL; Pallecchi L; Rossolini GM
    Int J Infect Dis; 2016 Feb; 43():1-6. PubMed ID: 26686940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermethod comparability analyses of gepotidacin antimicrobial susceptibility tests using a large collection of globally collected Escherichia coli and Staphylococcus saprophyticus clinical isolates.
    Arends SJR; Butler D; Scangarella-Oman N; Castanheira M; Mendes R
    Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116181. PubMed ID: 38215519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Resistance in Bacteria Causing Urinary Tract Infections.
    Salh KK
    Comb Chem High Throughput Screen; 2022; 25(7):1219-1229. PubMed ID: 34161207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain.
    García-Meniño I; Lumbreras P; Lestón L; Álvarez-Álvarez M; García V; Hammerl JA; Fernández J; Mora A
    Microbiol Spectr; 2022 Jun; 10(3):e0004122. PubMed ID: 35604206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020.
    Dunne MW; Aronin SI; Yu KC; Watts JA; Gupta V
    BMC Infect Dis; 2022 Feb; 22(1):194. PubMed ID: 35227203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.
    Hayami H; Takahashi S; Ishikawa K; Yasuda M; Yamamoto S; Uehara S; Hamasuna R; Matsumoto T; Minamitani S; Watanabe A; Iwamoto A; Totsuka K; Kadota J; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Naito S; Tatsugami K; Yamaguchi T; Ito S; Kanokogi M; Narita H; Kawano H; Hosobe T; Takayama K; Sumii T; Fujii A; Sato T; Yamauchi T; Izumitani M; Chokyu H; Ihara H; Akiyama K; Yoshioka M; Uno S; Monden K; Kano M; Kaji S; Kawai S; Ito K; Inatomi H; Nishimura H; Ikuyama T; Nishi S; Takahashi K; Kawano Y; Ishihara S; Tsuneyoshi K; Matsushita S; Yamane T; Hirose T; Fujihiro S; Endo K; Oka Y; Takeyama K; Kimura T; Uemura T
    J Infect Chemother; 2013 Jun; 19(3):393-403. PubMed ID: 23640203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the Prevalence of Antimicrobial Resistance in Escherichia coli Isolated from Outpatient Urine Cultures in French Amazonia.
    Nkontcho Djamkeba F; Sainte-Rose V; Lontsi Ngoulla GR; Roujansky A; Abboud P; Walter G; Houcke S; Demar M; Kallel H; Pujo JM; Djossou F
    Am J Trop Med Hyg; 2024 Aug; 111(2):287-296. PubMed ID: 38917783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.